COMMUNIQUÉS West-GlobeNewswire

AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast on Thursday, February 7, 2019 at 8:00 a.m. ET
30/01/2019
WALTHAM, Mass., Jan. 30, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its fourth quarter and full year 2018 financial results will be released on Thursday, February 7, 2019 [...]
CytomX Therapeutics to Host Research and Development Day on February 26, 2019
30/01/2019
SOUTH SAN FRANCISCO, Calif., Jan. 30, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
BioTime Inc. Affiliate Company OncoCyte Corporation Reports Successful Results With DetermaVu™ Diagnostic Test for Lung Cancer
30/01/2019
ALAMEDA, Calif., Jan. 30, 2019 (GLOBE NEWSWIRE) -- BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that its affiliate company, OncoCyte [...]
Aduro Biotech Announces Strategic Reset
30/01/2019
BERKELEY, Calif., Jan. 30, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced a strategic reset to focus on Aduro’s core strengths – discovery and development of novel product candidates in the [...]
Le Dr. Eric Simpson présentera les résultats obtenus avec bermekimab dans le traitement de la dermatite atopique lors de l’Assemblée annuelle 2019 de l’American Academy of Dermatology (AAD)
30/01/2019
Bermekimab assure un traitement rapide de la dermatite atopique, parallèlement à une diminution des démangeaisons et de la douleur AUSTIN, Texas, 30 janv. 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ : XBIT) a annoncé [...]
TG Therapeutics, Inc. Announces Publication of Clinical Data from the Phase I Triple Therapy Combination Trial of Ublituximab, Umbralisib, and Ibrutinib in The Lancet Haematology
30/01/2019
NEW YORK, Jan. 30, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the publication of results from the multicenter Phase 1 triple combination trial of ublituximab (TG-1101), the Company’s [...]
Stemline Therapeutics Announces Validation of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA)
30/01/2019
NEW YORK, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, today [...]
Aino Health AB (publ): Aino Health signs partnership agreement with Uudenmaan Työterveys, (Nylands Arbetshälsa)
30/01/2019
30 January 2019 Aino Health and Uudenmaan Työterveys, (Nylands Arbetshälsa), have signed a partnership agreement regarding Aino's SaaS solution HealthManager and Aino's consulting services in preventive healthcare. The [...]
Kamada Appoints Senior Biopharmaceutical Executive Michal Ayalon, Ph.D., as Vice President of Research and Development
30/01/2019
REHOVOT, Israel, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, announced today the appointment of Michal Ayalon, Ph.D., as Vice President of [...]
Mithra Announces Positive Top-line Results of Estelle® Phase III Oral Contraceptive Study in U.S/Canada
30/01/2019
Mithra Announces Positive Top-line Results of Estelle ® Phase III Oral Contraceptive Study in U.S/Canada Primary efficacy endpoint indicates excellent contraceptive efficacy, with a Pearl Index (PI) of 2.41 1 per 100 [...]
Emerald Health Therapeutics Announces Discharge of Litigation
30/01/2019
VANCOUVER, British Columbia, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) announced today that its wholly-owned subsidiary, Verdélite Sciences Inc. (“Verdélite [...]
Eyenovia Announces Positive Results in the MicroStat MIST-1 Phase III Registration Study for Mydriasis
30/01/2019
MIST-1 study met primary endpoint First-in-class fixed combination mydriatic agent demonstrated robust efficacy, high tolerability; Study further validates OpteJet™ platform delivery technology Company to host [...]
Trevena Announces $10 Million Registered Direct Offering of Common Stock
30/01/2019
CHESTERBROOK, Pa., Jan. 30, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN) (the “Company”) today announced that it entered into securities purchase agreements with two healthcare-focused institutional investors, [...]
Axsome Therapeutics Initiates Phase 2 Trial of AXS-12 in Narcolepsy
30/01/2019
Topline results anticipated in 2Q 2019 NEW YORK, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of [...]
Terveystalo Plc: Proposals of the Shareholders Nomination Board to the Annual General Meeting 2019
30/01/2019
Terveystalo Plc Stock Exchange Release 30 January 2019 at 13:00 EET The Shareholders' Nomination Board of Terveystalo has submitted its proposal on the Board of Directors to the Annual General Meeting 2019. Proposal on [...]
Release date of annual report 2018 for ALK and audio cast
30/01/2019
On Thursday, 7 February 2019, ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) releases its annual report for 2018. ALK will host a meeting for analysts and institutional investors that day at 12.30 p.m. (CET) at which [...]
Enzymatica AB: First patients included in large placebo-controlled multicentre study on ColdZyme
30/01/2019
Press release 30 January 2019 First patients included in large placebo-controlled multicentre study on ColdZyme Enzymatica has initiated a prospective double-blind, placebo-controlled multicentre study to evaluate the [...]
Changes to the Nomination Committee for Immunicum AB (publ)
30/01/2019
Press Release 30 January 2019 Changes to the Nomination Committee for Immunicum AB (publ) Immunicum AB (publ) (the "Company" or "Immunicum") announced the composition of the Nomination Committee on 19 October 2018. As a [...]
Curetis’ Unyvero Application Cartridges Receive Regulatory Approvals in Malaysia and Thailand
30/01/2019
HPN Cartridge approved in Malaysia; HPN, BCU Cartridges approved in Thailand Further commercial roll-out of Unyvero in ASEAN region by partner Acumen Research Laboratories facilitated Near-term Chinese NMPA submission [...]

Pages